These data indicate that AIH treatment significantly reduced MMP-9, IL-1R, TNFR, and TLR protein levels in the infarcted brain area compared to the MCAO, NT, and HT(0.5) groups (P < 0.05, Figure 6(b)). The gene discussed is MMP9; the disease is autoimmune hepatitis.